Review



primary human pulmonary arterial endothelial cells (paecs) cc-2530  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Lonza primary human pulmonary arterial endothelial cells (paecs) cc-2530
    Primary Human Pulmonary Arterial Endothelial Cells (Paecs) Cc 2530, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/pm40179885-679-0-8?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human pulmonary arterial endothelial cells (paecs) cc-2530 - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    95
    PromoCell human pulmonary artery endothelial cells paecs
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Human Pulmonary Artery Endothelial Cells Paecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/bio_rxiv__2024__02__20__578386-45-0-9?v=PromoCell
    Average 95 stars, based on 1 article reviews
    human pulmonary artery endothelial cells paecs - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    PromoCell primary human paecs
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Primary Human Paecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/bio_rxiv__2025__05__02__651303-218-0-6?v=PromoCell
    Average 95 stars, based on 1 article reviews
    primary human paecs - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    90
    Lonza primary human pulmonary arterial endothelial cells (paecs) cc-2530
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Primary Human Pulmonary Arterial Endothelial Cells (Paecs) Cc 2530, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/pm40179885-679-0-8?v=Lonza
    Average 90 stars, based on 1 article reviews
    primary human pulmonary arterial endothelial cells (paecs) cc-2530 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    99
    ATCC human pulmonary arterial ecs paecs
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Human Pulmonary Arterial Ecs Paecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/10__1161_slash_jaha__124__034726-95-7-14?v=ATCC
    Average 99 stars, based on 1 article reviews
    human pulmonary arterial ecs paecs - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    90
    Procell Inc primary human and mouse pulmonary artery endothelial cells (paecs)
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Primary Human And Mouse Pulmonary Artery Endothelial Cells (Paecs), supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/pm39462326-78-3-13?v=Procell+Inc
    Average 90 stars, based on 1 article reviews
    primary human and mouse pulmonary artery endothelial cells (paecs) - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    99
    ATCC human paecs
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Human Paecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/pm39408838-226-6-8?v=ATCC
    Average 99 stars, based on 1 article reviews
    human paecs - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    95
    PromoCell human paecs
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Human Paecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/10__1165_slash_rcmb__2023___0308oc-69-0-5?v=PromoCell
    Average 95 stars, based on 1 article reviews
    human paecs - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    95
    PromoCell pulmonary artery endothelial cell paec paecs
    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in <t>PAECs</t> and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular <t>endothelial</t> cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.
    Pulmonary Artery Endothelial Cell Paec Paecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+pulmonary+artery+endothelial+cells+paec/pm38243138-382-0-9?v=PromoCell
    Average 95 stars, based on 1 article reviews
    pulmonary artery endothelial cell paec paecs - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in PAECs and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular endothelial cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.

    Journal: bioRxiv

    Article Title: STING contributes to pulmonary hypertension by targeting the interferon and BMPR2 signaling through targeting F2RL3

    doi: 10.1101/2024.02.20.578386

    Figure Lengend Snippet: A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in total lung tissues from PH patients and healthy controls (n=5-11). B , Protein expression levels of STING in the total lung tissues of PH patients and healthy controls (n=4). C , Representative colocalization staining of STING (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. D , Protein expression levels of STING in PAECs and PASMCs (n=4). E, Relative mRNA expression of STING in PAEC exposure to 1% O 2 hypoxia for 24h (n=4). F, Relative mRNA expression of Sting in lung microvascular endothelial cells from hypoxia and SuHx mouse PH models (n=4). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using Unpaired t test for A, B, D, and E. Statistical analysis was done using One-way ANOVA for F.

    Article Snippet: Human pulmonary artery endothelial cells (PAECs) were purchased from Promcell (C-12241).

    Techniques: Expressing, Staining

    A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in PAECs with TNF-α (2ng/ml) treatment for 24h (n=3). B-D , Protein expression levels of cGAS, p-STING/STING, p-IRF3/IRF3, and p-TBK1/TBK1 in PAECs with TNF-α (2ng/ml) treatment for 24 h (n=3). E , Protein expression levels of p-IRF3/IRF3, and p-TBK1/TBK1 in PAECs with siRNA STING and siRNA negative control (NC) transfection and followed by TNF-α (2ng/ml) treatment for 24 h (n=3). P , Protein expression levels of p-IRF3/IRF3, and p-TBK1/TBK1 in PAEC with H-151 (DMSO) treatment and followed by TNF-α (2ng/ml) treatment for 24 h (n=3). G , Relative mRNA expression profiles of interferon-stimulated genes (ISGs) ( IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in PAECs transfected by siRNA STING and siRNA negative control (NC) and followed with or without TNF-α (2ng/ml) treatment for 24 h (n=3). H , Relative mRNA expression profiles of interferon-stimulated genes (ISGs) ( IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in PAECs with H-151 (DMSO) treatment and followed with or without TNF-α (2ng/ml) treatment for 24 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for A-F. Statistical analysis was done using a two-way ANOVA with multiple comparisons for G-H.

    Journal: bioRxiv

    Article Title: STING contributes to pulmonary hypertension by targeting the interferon and BMPR2 signaling through targeting F2RL3

    doi: 10.1101/2024.02.20.578386

    Figure Lengend Snippet: A , Relative mRNA expression profiles of cGAS-STING pathway genes ( cGAS, STING, IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in PAECs with TNF-α (2ng/ml) treatment for 24h (n=3). B-D , Protein expression levels of cGAS, p-STING/STING, p-IRF3/IRF3, and p-TBK1/TBK1 in PAECs with TNF-α (2ng/ml) treatment for 24 h (n=3). E , Protein expression levels of p-IRF3/IRF3, and p-TBK1/TBK1 in PAECs with siRNA STING and siRNA negative control (NC) transfection and followed by TNF-α (2ng/ml) treatment for 24 h (n=3). P , Protein expression levels of p-IRF3/IRF3, and p-TBK1/TBK1 in PAEC with H-151 (DMSO) treatment and followed by TNF-α (2ng/ml) treatment for 24 h (n=3). G , Relative mRNA expression profiles of interferon-stimulated genes (ISGs) ( IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in PAECs transfected by siRNA STING and siRNA negative control (NC) and followed with or without TNF-α (2ng/ml) treatment for 24 h (n=3). H , Relative mRNA expression profiles of interferon-stimulated genes (ISGs) ( IRF3, IRF7, IFIT1, IFIT2, IFIT3 and CXCL10 ) in PAECs with H-151 (DMSO) treatment and followed with or without TNF-α (2ng/ml) treatment for 24 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for A-F. Statistical analysis was done using a two-way ANOVA with multiple comparisons for G-H.

    Article Snippet: Human pulmonary artery endothelial cells (PAECs) were purchased from Promcell (C-12241).

    Techniques: Expressing, Negative Control, Transfection, Two Tailed Test

    A and B , The positive EdU staining of proliferating PAECs transfected with siRNA STING and siRNA NC were detected by fluorescent microscopy and absorbance measurement (n =3 and 6). C and D , The positive EdU staining of proliferating PAECs treated with H-151 (DMSO) were detected by fluorescent microscopy and absorbance measurement (n =3 and 6). E and F , Protein expression levels of PCNA in PAECs transfected with siRNA STING (NC) or treated with H-151(DMSO) (n=3). G and H , the relative migration distances were analyzed by wound healing assay in PAECs transfected with siRNA STING (NC) or treated with H-151(DMSO) (n=3). I , The protein levels ICAM-1 and STING in PAECs transfected with siRNA STING (NC) and stimulated with or without TNF-α (2ng/ml) for 24 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for A-H. Statistical analysis was done using a two-way ANOVA with multiple comparisons for I.

    Journal: bioRxiv

    Article Title: STING contributes to pulmonary hypertension by targeting the interferon and BMPR2 signaling through targeting F2RL3

    doi: 10.1101/2024.02.20.578386

    Figure Lengend Snippet: A and B , The positive EdU staining of proliferating PAECs transfected with siRNA STING and siRNA NC were detected by fluorescent microscopy and absorbance measurement (n =3 and 6). C and D , The positive EdU staining of proliferating PAECs treated with H-151 (DMSO) were detected by fluorescent microscopy and absorbance measurement (n =3 and 6). E and F , Protein expression levels of PCNA in PAECs transfected with siRNA STING (NC) or treated with H-151(DMSO) (n=3). G and H , the relative migration distances were analyzed by wound healing assay in PAECs transfected with siRNA STING (NC) or treated with H-151(DMSO) (n=3). I , The protein levels ICAM-1 and STING in PAECs transfected with siRNA STING (NC) and stimulated with or without TNF-α (2ng/ml) for 24 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for A-H. Statistical analysis was done using a two-way ANOVA with multiple comparisons for I.

    Article Snippet: Human pulmonary artery endothelial cells (PAECs) were purchased from Promcell (C-12241).

    Techniques: Staining, Transfection, Microscopy, Expressing, Migration, Wound Healing Assay, Two Tailed Test

    A and B , Downregulated Gene ontology (GO) terms and KEGG pathways analysis from the bulk RNA-sequencing (RNA-seq) in PAECs with STING silencing and followed by TNF-α (2ng/ml) treatment for 24 hours. C , Heatmap showing dysregulated gene expression and highlighting the F2RL3 in Complement and coagulation cascades. D , Volcano plot showing the differentially expressed genes in PAECs and highlights the F2RL3. E , Relative mRNA expression of STING and F2RL3 in PAECs treated with siSTING versus siNC (siNegative Control) (n=3). F , The protein levels of F2RL3 and STING in PAECs with siRNA STING transfection (n=3). G, The protein levels of phosphorylation of NF-κB p65 in PAECs treated with siSTING versus siNC±TNF-α (2ng/ml) treatment for 24 h (n=3). H, Schematic illustration shows the potential NF-κB binding sites of the F2RL3 promoter region, and agarose gel electrophoresis to assess the PCR reactions from the ChIP samples. I, Dual luciferase assay showing the transcriptional regulation of NF-κB on F2RL3 WT and mutants in 293T cells. J, Co-immunoprecipitation (Co-IP) in PAECs to assess the interaction between STING and F2RL3. K, Relative mRNA expression of F2RL3 in lung tissues from PH patients and healthy controls (n=5-12). L, Representative colocalization staining of F2RL3 (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. M, The protein levels of p-STING/STING and p-TBK1/TBK1 in PAECs treated with siF2RL3 versus siNC±TNF-α (2ng/ml) treatment for 24 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for E,F,and K. Statistical analysis was done using a two-way ANOVA with multiple comparisons for G,I, and M.

    Journal: bioRxiv

    Article Title: STING contributes to pulmonary hypertension by targeting the interferon and BMPR2 signaling through targeting F2RL3

    doi: 10.1101/2024.02.20.578386

    Figure Lengend Snippet: A and B , Downregulated Gene ontology (GO) terms and KEGG pathways analysis from the bulk RNA-sequencing (RNA-seq) in PAECs with STING silencing and followed by TNF-α (2ng/ml) treatment for 24 hours. C , Heatmap showing dysregulated gene expression and highlighting the F2RL3 in Complement and coagulation cascades. D , Volcano plot showing the differentially expressed genes in PAECs and highlights the F2RL3. E , Relative mRNA expression of STING and F2RL3 in PAECs treated with siSTING versus siNC (siNegative Control) (n=3). F , The protein levels of F2RL3 and STING in PAECs with siRNA STING transfection (n=3). G, The protein levels of phosphorylation of NF-κB p65 in PAECs treated with siSTING versus siNC±TNF-α (2ng/ml) treatment for 24 h (n=3). H, Schematic illustration shows the potential NF-κB binding sites of the F2RL3 promoter region, and agarose gel electrophoresis to assess the PCR reactions from the ChIP samples. I, Dual luciferase assay showing the transcriptional regulation of NF-κB on F2RL3 WT and mutants in 293T cells. J, Co-immunoprecipitation (Co-IP) in PAECs to assess the interaction between STING and F2RL3. K, Relative mRNA expression of F2RL3 in lung tissues from PH patients and healthy controls (n=5-12). L, Representative colocalization staining of F2RL3 (red), vWF (red) and α-SMA (green) in pulmonary arteries of healthy controls and PH patients (n=4), Scale bar=20μm. M, The protein levels of p-STING/STING and p-TBK1/TBK1 in PAECs treated with siF2RL3 versus siNC±TNF-α (2ng/ml) treatment for 24 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for E,F,and K. Statistical analysis was done using a two-way ANOVA with multiple comparisons for G,I, and M.

    Article Snippet: Human pulmonary artery endothelial cells (PAECs) were purchased from Promcell (C-12241).

    Techniques: RNA Sequencing, Gene Expression, Coagulation, Expressing, Control, Transfection, Phospho-proteomics, Binding Assay, Agarose Gel Electrophoresis, Luciferase, Immunoprecipitation, Co-Immunoprecipitation Assay, Staining, Two Tailed Test

    A , Heatmap showing the dysregulated gene expression associated with the BMP signaling pathway. B , Relative mRNA expression of BMPR1A , BMPR2 and ID3 in PAECs treated with siSTING versus siNC (siNegative Control) +BMP9 (10ng/ml) treatment for 24 h (n=3). C-D , The protein levels of BMPR2 and p-Smad1/5/9 in PAECs treated with siSTING versus siNC±BMP9 (10ng/ml) treatment (n=3). E-F , The protein levels of p-Smad1/5/9, Smad1, F2RL3 and STING in PAECs treated with siF2RL3 versus siNC±BMP9 (10ng/ml) treatment for 24 h (n=3). G , Relative mRNA expression of STING , F2RL3 , BMPR2 , ID1 and ID3 in PAECs with BMP9 (10ng/ml) (n=3). H-I , The protein levels of F2RL3 and STING in PAEC with BMP9 (10ng/ml) treatment (n=3). J-K , The protein levels of BMPR2 and F2RL3 in PAECs transfected with siRNA BMPR2 and siRNA NC (n=3). L, Relative mRNA expression of BMPR2 and F2RL3 in PAECs transfected with siRNA BMPR2 and siRNA NC (n=3). M-N , The protein levels of BMPR2, p-Smad1/5/9, STING, and F2RL3 in PAECs transfected with siRNA STING and siRNA NC followed by lentivirus NC (LV-NC) and lentivirus F2RL3 (LV-F2RL3) infection 48 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for B, G, I, K, and L. Statistical analysis was done using a two-way ANOVA with multiple comparisons for D, F, and N.

    Journal: bioRxiv

    Article Title: STING contributes to pulmonary hypertension by targeting the interferon and BMPR2 signaling through targeting F2RL3

    doi: 10.1101/2024.02.20.578386

    Figure Lengend Snippet: A , Heatmap showing the dysregulated gene expression associated with the BMP signaling pathway. B , Relative mRNA expression of BMPR1A , BMPR2 and ID3 in PAECs treated with siSTING versus siNC (siNegative Control) +BMP9 (10ng/ml) treatment for 24 h (n=3). C-D , The protein levels of BMPR2 and p-Smad1/5/9 in PAECs treated with siSTING versus siNC±BMP9 (10ng/ml) treatment (n=3). E-F , The protein levels of p-Smad1/5/9, Smad1, F2RL3 and STING in PAECs treated with siF2RL3 versus siNC±BMP9 (10ng/ml) treatment for 24 h (n=3). G , Relative mRNA expression of STING , F2RL3 , BMPR2 , ID1 and ID3 in PAECs with BMP9 (10ng/ml) (n=3). H-I , The protein levels of F2RL3 and STING in PAEC with BMP9 (10ng/ml) treatment (n=3). J-K , The protein levels of BMPR2 and F2RL3 in PAECs transfected with siRNA BMPR2 and siRNA NC (n=3). L, Relative mRNA expression of BMPR2 and F2RL3 in PAECs transfected with siRNA BMPR2 and siRNA NC (n=3). M-N , The protein levels of BMPR2, p-Smad1/5/9, STING, and F2RL3 in PAECs transfected with siRNA STING and siRNA NC followed by lentivirus NC (LV-NC) and lentivirus F2RL3 (LV-F2RL3) infection 48 h (n=3). Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.01. Statistical analysis was done using unpaired two-tailed t test for B, G, I, K, and L. Statistical analysis was done using a two-way ANOVA with multiple comparisons for D, F, and N.

    Article Snippet: Human pulmonary artery endothelial cells (PAECs) were purchased from Promcell (C-12241).

    Techniques: Gene Expression, Expressing, Control, Transfection, Infection, Two Tailed Test